| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 May 2026 | 7 May 2026 |
| Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve 1. Approval of Audited Financial Results for the period ended March 31 2026. 2. Any other business | ||
| Board Meeting | 6 May 2026 | 6 May 2026 |
| The Board of Directors approved inter-alia the following; 1. Appointment of Mr. Ramesh Sharma (DIN: 10728184) as a Non-Executive Independent Director (Additional). 2. Appointment of Ms. Geetika Garg (DIN: 10643307) as a Non-Executive Independent Director (Additional). 3. Resignation of Ms. Sonalben Vaghela (DIN:11268799) as Non-Executive Independent Director. 4. Resignation of Mr. Jaykumar Bhaveshkumar Patel (DIN: 11212605) as Non-Executive Independent Director. 5. Reconstitution of the Audit Committee, Nomination & Remuneration Committee and Stakeholder Relationship Committee. | ||
| Board Meeting | 11 Apr 2026 | 11 Apr 2026 |
| Allotment Of 78,15,000 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 78,15,000 Fully Convertible Equity Warrants (Warrants) | ||
| Board Meeting | 16 Feb 2026 | 16 Feb 2026 |
| Board Meeting Outcome for For Allotment Of 1,30,90,200 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 1,30,90,200 Fully Convertible Equity Warrants (Warrants) | ||
| Board Meeting | 13 Feb 2026 | 13 Feb 2026 |
| Allotment Of 38,85,000 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 38,85,000 Fully Convertible Equity Warrants. | ||
| Board Meeting | 12 Feb 2026 | 12 Feb 2026 |
| Allotment Of 8,14,800 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 8,14,800 Fully Convertible Equity Warrants (Warrants) | ||
| Board Meeting | 11 Feb 2026 | 12 Feb 2026 |
| Allotment Of 1,95,25,000 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 1,95,25,000 Fully Convertible Equity Warrants | ||
| Board Meeting | 10 Feb 2026 | 10 Feb 2026 |
| Allotment Of 1,56,60,000 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 1,56,60,000 Fully Convertible Equity Warrants (Warrants) | ||
| Board Meeting | 9 Feb 2026 | 9 Feb 2026 |
| Outcome of Board Meeting | ||
| Board Meeting | 6 Feb 2026 | 6 Feb 2026 |
| Allotment Of Fully Convertible Equity Warrants On A Preferential Basis. | ||
| Board Meeting | 5 Feb 2026 | 5 Feb 2026 |
| Allotment Of 1,30,90,200 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 7,25,00,000 Fully Convertible Equity Warrants (Warrants). Outcome of Board Meeting for Allotment of 2,42,29,800 fully Convertible Equity Warrants on a preferential basis. | ||
| Board Meeting | 4 Feb 2026 | 4 Feb 2026 |
| Allotment Of 1,17,00,000 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 7,25,00,000 Fully Convertible Equity Warrants (Warrants) | ||
| Board Meeting | 27 Jan 2026 | 27 Jan 2026 |
| Approved draft of Notice of Extra-Ordinary General Meeting to be held on Friday, February 20, 2026. | ||
| Board Meeting | 24 Jan 2026 | 20 Jan 2026 |
| Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2026 inter alia to consider and approve To consider and approve Un-audited financial results of the company for the period ended on December 31 2025. OUTCOME OF THE BOARD OF DIRECTORS MEETING HELD ON JANUARY 24, 2026 Outcome of Board Meeting held on January 24, 2026 (As Per BSE Announcement Dated on:24.01.2026) | ||
| Board Meeting | 4 Dec 2025 | 4 Dec 2025 |
| Appointment of Mr. Vaibhav Jakhaniya (Membership Number: A78354) as Company Secretary and Compliance Officer of the Company w.e.f., December 04, 2025 | ||
| Board Meeting | 11 Nov 2025 | 6 Nov 2025 |
| Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve 1. Un-audited financial results of the company for the period ended on September 30 2025. 2. Any other business matter with the permission of the Chair. The Board of Directors of the Company at their meeting held on November 11, 2025 have inter alia approved; Unaudited Standalone Financial Results of the Company for the period ended on September 30, 2025 . (As Per BSE Announcement Dated on 11.11.2025) | ||
| Board Meeting | 3 Nov 2025 | 3 Nov 2025 |
| APPOINTMENT OF M/S. S K BHAVSAR & CO. AS THE STATUTORY AUDITOR OF THE COMPANY. Clarification with respect to outcome of Board Meeting held on November 03, 2025 (As per BSE Announcement dated on: 05.11.2025) | ||
| Board Meeting | 6 Oct 2025 | 6 Oct 2025 |
| Outcome of Meeting of the Board of Directors held on Monday, October 06, 2025, with respect to change in registered office. Clarification with respect to outcome of board meeting held on October 06, 2025. (As Per Bse Announcement dated on 10/10/2025) | ||
| Board Meeting | 4 Oct 2025 | 4 Oct 2025 |
| Board hereby considered and approved shifting of Registered Office of the Company within local limits. | ||
| Board Meeting | 30 Sep 2025 | 30 Sep 2025 |
| The Board: 1. Considered and approved alteration of Object Clause in Memorandum of Association of the Company. 2. Considered and approved the adoption of new set of Memorandum of Association and Articles of Association of the company 3. Considered and approved the adoption of new set of Articles of Association. 4. Any other business matter with the permission of Chair. | ||
| Board Meeting | 24 Sep 2025 | 19 Sep 2025 |
| Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/09/2025 inter alia to consider and approve 1. To consider and evaluate the proposal for fund raising by way of issue of any instrument or securities through qualified institutional placement private placement/ preferential issue of securities/Right issue or through any other permissible mode and/ or combination thereof as may be considered appropriate subject to such regulatory approvals as may be required including the approval of the members at a general meeting or through postal ballot and further subject to such statutory / regulatory approvals as applicable. 2. Any other business matter with the permission of Chair. Outcome of the Meeting of the Board of Directors held on 24.09.2025 (As Per Bse Announcement dated on 24/09/2025) Revised outcome of Board meeting held on September 24, 2025 (As Per BSE Announcement Dated on 29.09.2025) | ||
| Board Meeting | 20 Sep 2025 | 20 Sep 2025 |
| Considered and approved the shifting of the Corporate Office of the Company. (As Per BSE Announcement Dated On : 20.09.2025) | ||
| Board Meeting | 30 Aug 2025 | 30 Aug 2025 |
| With reference to the captioned subject, we wish to inform your good office that the Board of Directors of the Company, at their meeting held today i.e., Saturday, August 30, 2025, have, inter alia, transacted and approved the following businesses: 01. Approved the Draft Directors Report for the financial year ended March 31, 2025. 02. Notice of 33rd Annual General Meeting Clarification with respect to Board Meeting Outcome dated August 30, 2025. (As Per Bse Announcement dated on 12/09/2025) | ||
| Board Meeting | 29 Aug 2025 | 29 Aug 2025 |
| Pursuant to Regulation 30 of SEBI LODR, 2015 the Company has appointed Ms. Sonal Vaghela as Non-Executive - Independent Director of the Company. | ||
| Board Meeting | 12 Aug 2025 | 5 Aug 2025 |
| Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Mardia Samyoung Capillary Tubes Company Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended 30th June 2025. Unaudited Standalone Financial Results of the company for the Quarter ended June 30, 2025 (As Per BSE Announcement Dated on:12.08.2025) | ||
| Board Meeting | 30 May 2025 | 22 May 2025 |
| Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve To consider and to approve the audited financial results of the Company for the financial Year ended March 31 2025 pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 OUTCOME OF BOARD MEETING DATED 30TH MAY, 2025 FOR APPROVAL OF AUDITED FINANCIAL RESULTS FOR THE FINANCIAL YEAR 2024 - 2025 (As per BSE Announcement Dated on 30/05/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
